SEC Form D · Amendment · filed August 23, 2012
SynerGene Therapeutics, Inc
Offering
$2.0M
Sold
$1.1M
Exemption
—
Industry
Biotechnology
Location
POTOMAC, MD
Type
—
People & firms on this filing (6)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗